DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slipped 1.03% to $20.08 Monday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.45% to 21,798.70 and the Dow Jones Industrial Average rising 0.25% to 45,514.95.
The stock's fall snapped a two-day winning streak.
Catalyst Pharmaceuticals Inc. closed 24.45% below its 52-week high of $26.58, which the company achieved on June 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson $(JNJ)$ fell 0.17% to $178.13, Pfizer Inc. $(PFE)$ fell 1.33% to $24.55, and Abbott Laboratories $(ABT)$ fell 0.56% to $132.20.
Trading volume (2.4 M) eclipsed its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
September 08, 2025 17:25 ET (21:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.